Adare Pharma Solutions

Duragran™

Duragran^™

Duragran^™ allows for more uniformity and precise control of targeted particle sizes while providing production time and cost saving The Duragran^™ patented process eliminates the need for extrusion and spheronization for high API-loaded drug particulates by using our fluid bed processing technology that combines the particle sizing and coating processes to create controlled-release beads/granules of uniform and narrow particle size range or the need to layer product onto a uniform sized sugar bead.

Duragran^™ allows us to create controlled release beadlets/granules of uniform and narrow particle size range without the use of spheronization/extrusion equipment or the need to layer product onto a uniform sized sugar bead.

Duragran^™ for more uniformity and targeted sizing

Duragran™ creates granules of more uniform particle size with easily modified process parameters that can be used to target a desired particle size that standard wet granulation processes cannot attain. The technology can be applied to controlled-release formulations and to create taste-masked, orally disintegrating tablet formulations.

Duragran^™ provides many benefits by reducing:

• Overall production costs
• Energy requirements
• Quality Unit in-process monitoring